Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V0HU
|
|||
| Former ID |
DIB000895
|
|||
| Drug Name |
IFN alpha kinoid
|
|||
| Synonyms |
Antiferon; IFNa kinoid; IFN-K; Inactivated IFN alpha + keyhole limpet hemocyanin (SLE/HIV), Neovacs; Anti-interferonalpha (HIV/SLE), Neovacs/sanofi pasteur
Click to Show/Hide
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 1/2 | [1] | |
| Company |
Neovacs SA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01058343) Safety of IFNa Kinoid in Systemic Lupus Erythematosus. U.S. National Institutes of Health. | |||
| REF 2 | Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon alpha-kinoid. Arthritis Rheum. 2013 Feb;65(2):447-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.